Skip to main content
. 2014 Dec 17;308(5):R370–R378. doi: 10.1152/ajpregu.00366.2014

Fig. 1.

Fig. 1.

Characterization of synapsin-loxp-hACE2 (SL) transgenic mice. A: schematic of the human (h) angiotensin-converting enzyme type 2 (ACE2) transgene flanked by LoxP sites and driven by a rat synapsin promoter. B: ACE2 activity assay showing that SL mice present significantly higher enzyme activity in the brain compared with nontransgenic (NT) mice. C: baseline mean arterial blood pressure (MAP) was not different in SL mice compared with NT mice.